Key Highlights

● Pfizer touched a 52-week high on Friday, October 30, 2026.

● The drugmaker had no company-specific news and moved with its sector.

● Health care stocks hit a record high as investors sold chips.

● Pfizer reports Earnings on Tuesday, November 3.

Pfizer (NYSE:PFE) touched a 52-week high on Friday, October 30, 2026. The New York-based drugmaker had no company-specific news on the day; it moved with the health care sector, which hit a record high, according to market data.

The advance reflected a sweeping rotation. Investors pulled money out of semiconductors, artificial intelligence names and megacap technology after a series of weak results and moved it into defensive areas of the market. Health care, consumer staples, utilities and energy were the main beneficiaries.

Pfizer, one of the world's largest pharmaceutical companies, sells medicines and vaccines across a wide range of therapeutic areas. Drugmakers are often seen as defensive because Demand for medicine tends to hold up regardless of economic conditions.

A crowded rally

Pfizer had plenty of company. Regeneron Pharmaceuticals (NASDAQ:REGN) was the top gainer in the S&P 500 after reporting third-quarter Revenue of $5.12 billion, far above the $4.54 billion forecast. AbbVie (NYSE:ABBV) hit a 52-week high after beating estimates and raising its outlook, and Eli Lilly (NYSE:LLY) and Johnson & Johnson (NYSE:JNJ) also reached 52-week highs. Gilead Sciences (NASDAQ:GILD) rose on its own strong quarter.

Johnson & Johnson and Cardinal Health, like Pfizer, moved with the sector rather than on company-specific news.

Chips in free fall

The rush into health care was a direct response to the turmoil in technology. Intel (NASDAQ:INTC) plunged after issuing a fourth-quarter revenue forecast of $15 billion to $16 billion, well short of expectations, and warning of cash burn this year. The company cited a weak PC market, Manufacturing bottlenecks and a factory accident in Israel.

The fallout spread across the chip industry. Advanced Micro Devices (NASDAQ:AMD), Qualcomm (NASDAQ:QCOM), Nvidia (NASDAQ:NVDA), Broadcom (NASDAQ:AVGO) and Micron (NASDAQ:MU) all fell, and the Philadelphia Semiconductor index closed at 10,688.80. Amazon (NASDAQ:AMZN)'s results, which showed negative trailing free cash flow, and continued losses in Alphabet (NASDAQ:GOOGL) after its record drop on Thursday added to worries about the cost of the AI buildout.

The broader market suffered its worst day since June. The S&P 500 fell 140.32 points to 7,580.07, the Dow Jones Industrial Average lost 572.25 points to 51,770.31 and the Nasdaq Composite tumbled 747.73 points to 25,437.00, its worst session since June 5. The Russell 2000 dropped 47.37 points to 2,811.84.

A trading specialist said of the technology names: "A lot of them kind of got ahead of themselves. It's all earnings based and right now, they're not producing,"

Other forces added to the strain. Oil rose above $100 a barrel on tensions near the Strait of Hormuz, crypto stocks slid after Binance was reportedly hacked for about $6.3 billion, and markets increasingly expect the Federal Reserve to raise rates in December after it left its benchmark rate range unchanged on Wednesday.

What to watch

Pfizer's own results are next. The company reports on Tuesday, November 3, which will give investors a chance to judge whether its fundamentals support the stock's move to a 52-week high. Investors will look for updates on its pipeline and on demand for its medicines and vaccines.

That report lands on the same day as the midterm elections. Apple (NASDAQ:AAPL) reports on Monday, November 2, and the October jobs report arrives on Friday, November 6. Together, those events will help determine whether the rotation into health care continues or whether investors return to technology.